Khara M Sauro1,2, Andrea Soo1, Chloe de Grood1,2, Michael M H Yang3, Benjamin Wierstra1, Luc Benoit1, Philippe Couillard1,3, François Lamontagne4, Alexis F Turgeon5,6, Alan J Forster7, Robert A Fowler8, Peter M Dodek9, Sean M Bagshaw10, Henry T Stelfox1,2. 1. Department of Critical Care Medicine, University of Calgary and Alberta Health Services, Calgary, AB, Canada. 2. Department of Community Health Sciences and O'Brien Institute for Public Health, University of Calgary, Calgary, AB, Canada. 3. Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada. 4. Centre de Recherche du CHU de Sherbrooke et Université de Sherbrooke, Sherbrooke, QC, Canada. 5. Centre de Recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada. 6. Department of Anesthesiology and Critical Care Medicine, Division of Critical Care, Université Laval, Quebec City, QC, Canada. 7. Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada. 8. Department of Medicine and Critical Care Medicine, Sunnybrook Hospital, University of Toronto, Toronto, ON, Canada. 9. Division of Critical Care Medicine and Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital and University of British Columbia, Vancouver, BC, Canada. 10. Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta and Alberta Health Services, Edmonton, AB, Canada.
Abstract
OBJECTIVES: To examine adverse events and associated factors and outcomes during transition from ICU to hospital ward (after ICU discharge). DESIGN: Multicenter cohort study. SETTING: Ten adult medical-surgical Canadian ICUs. PATIENTS: Patients were those admitted to one of the 10 ICUs from July 2014 to January 2016. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Two ICU physicians independently reviewed progress and consultation notes documented in the medical record within 7 days of patient's ICU discharge date to identify and classify adverse events. The adverse event data were linked to patient characteristics and ICU and ward physician surveys collected during the larger prospective cohort study. Analyses were conducted using multivariable logistic regression. Of the 451 patients included in the study, 84 (19%) experienced an adverse event, the majority (62%) within 3 days of transfer from ICU to hospital ward. Most adverse events resulted only in symptoms (77%) and 36% were judged to be preventable. Patients with adverse events were more likely to be readmitted to the ICU (odds ratio, 5.5; 95% CI, 2.4-13.0), have a longer hospital stay (mean difference, 16.1 d; 95% CI, 8.4-23.7) or die in hospital (odds ratio, 4.6; 95% CI, 1.8-11.8) than those without an adverse event. ICU and ward physician predictions at the time of ICU discharge had low sensitivity and specificity for predicting adverse events, ICU readmissions, and hospital death. CONCLUSIONS: Adverse events are common after ICU discharge to hospital ward and are associated with ICU readmission, increased hospital length of stay and death and are not predicted by ICU or ward physicians.
OBJECTIVES: To examine adverse events and associated factors and outcomes during transition from ICU to hospital ward (after ICU discharge). DESIGN: Multicenter cohort study. SETTING: Ten adult medical-surgical Canadian ICUs. PATIENTS: Patients were those admitted to one of the 10 ICUs from July 2014 to January 2016. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Two ICU physicians independently reviewed progress and consultation notes documented in the medical record within 7 days of patient's ICU discharge date to identify and classify adverse events. The adverse event data were linked to patient characteristics and ICU and ward physician surveys collected during the larger prospective cohort study. Analyses were conducted using multivariable logistic regression. Of the 451 patients included in the study, 84 (19%) experienced an adverse event, the majority (62%) within 3 days of transfer from ICU to hospital ward. Most adverse events resulted only in symptoms (77%) and 36% were judged to be preventable. Patients with adverse events were more likely to be readmitted to the ICU (odds ratio, 5.5; 95% CI, 2.4-13.0), have a longer hospital stay (mean difference, 16.1 d; 95% CI, 8.4-23.7) or die in hospital (odds ratio, 4.6; 95% CI, 1.8-11.8) than those without an adverse event. ICU and ward physician predictions at the time of ICU discharge had low sensitivity and specificity for predicting adverse events, ICU readmissions, and hospital death. CONCLUSIONS: Adverse events are common after ICU discharge to hospital ward and are associated with ICU readmission, increased hospital length of stay and death and are not predicted by ICU or ward physicians.
Authors: Jorge Enrique Machado-Alba; Andrés Felipe Usma-Valencia; Nicolás Sánchez-Ramírez; Luis Fernando Valladales-Restrepo; Manuel Machado-Duque; Andrés Gaviria-Mendoza Journal: Drugs Real World Outcomes Date: 2021-04-07
Authors: Tyler J Loftus; Matthew M Ruppert; Tezcan Ozrazgat-Baslanti; Jeremy A Balch; Philip A Efron; Patrick J Tighe; William R Hogan; Parisa Rashidi; Gilbert R Upchurch; Azra Bihorac Journal: JAMA Netw Open Date: 2021-11-01
Authors: Richard S Bourne; Jennifer K Jennings; Maria Panagioti; Alexander Hodkinson; Anthea Sutton; Darren M Ashcroft Journal: BMJ Qual Saf Date: 2022-01-18 Impact factor: 7.418
Authors: David González-Calle; Eduardo Villacorta; Amparo Sánchez-Serrano; Marta León; Pedro L Sanchez Journal: Crit Care Med Date: 2020-12 Impact factor: 9.296